{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:04:10Z","timestamp":1786986250769,"version":"build-2736575974"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cellimm.2023.104778","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T04:50:11Z","timestamp":1698555011000},"page":"104778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Differential roles of regulatory T cells in Alzheimer's disease"],"prefix":"10.1016","volume":"393-394","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-0602","authenticated-orcid":false,"given":"Abdollah","family":"Jafarzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolkarim","family":"Sheikhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2023.104778_b0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cellimm.2023.104778_b0010","doi-asserted-by":"crossref","unstructured":"A.A. R, Risk factors for Alzheimer's disease, Folia neuropathologica, 57 (2019) 87-105.","DOI":"10.5114\/fn.2019.85929"},{"key":"10.1016\/j.cellimm.2023.104778_b0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet (london, England)"},{"key":"10.1016\/j.cellimm.2023.104778_b0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cellimm.2023.104778_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"NeuroMol. Med."},{"key":"10.1016\/j.cellimm.2023.104778_b0030","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2015.2428","article-title":"Experimental models of Alzheimer's disease for deciphering the pathogenesis and therapeutic screening","volume":"37","author":"Li","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cellimm.2023.104778_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.912995","article-title":"Mouse models of alzheimer\u2019s disease","volume":"15","author":"Yokoyama","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.cellimm.2023.104778_b0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/glia.20734","article-title":"Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology","volume":"57","author":"Desai","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.cellimm.2023.104778_b0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.cellimm.2023.104778_b0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-2-23","article-title":"Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice","volume":"2","author":"Janelsins","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellimm.2023.104778_b0055","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"Oakley","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.cellimm.2023.104778_b0060","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2174\/1871527313666140917095514","article-title":"Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus","volume":"13","author":"Ashraf","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.cellimm.2023.104778_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/638083","article-title":"Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging","volume":"2013","author":"Cuanalo-Contreras","year":"2013","journal-title":"International Journal of Cell Biology"},{"key":"10.1016\/j.cellimm.2023.104778_b0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-020-00375-7","article-title":"Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders","volume":"15","author":"Machhi","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cellimm.2023.104778_b0075","doi-asserted-by":"crossref","first-page":"1090109","DOI":"10.3389\/fnagi.2022.1090109","article-title":"Extensive accumulation of misfolded protein aggregates during natural aging and senescence","volume":"14","author":"Cuanalo-Contreras","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cellimm.2023.104778_b0080","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-020-01968-1","article-title":"The immune system on the TRAIL of Alzheimer\u2019s disease","volume":"17","author":"Burgaletto","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellimm.2023.104778_b0085","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3390\/cells10102581","article-title":"Inflammatory Cascade in Alzheimer\u2019s Disease Pathogenesis: A Review of Experimental Findings","volume":"10","author":"de Oliveira","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cellimm.2023.104778_b0090","doi-asserted-by":"crossref","unstructured":"J.W. Kinney, S.M. Bemiller, A.S. Murtishaw, A.M. Leisgang, A.M. Salazar, B.T. Lamb, Inflammation as a central mechanism in Alzheimer's disease, Alzheimer's & dementia (New York, N. Y.), 4 (2018) 575-590.","DOI":"10.1016\/j.trci.2018.06.014"},{"key":"10.1016\/j.cellimm.2023.104778_b0095","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellimm.2023.104778_b0100","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3389\/fimmu.2017.01905","article-title":"Neuroinflammation: Microglia and T Cells Get Ready to Tango","volume":"8","author":"Schetters","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-021-02308-7","article-title":"CD4+ effector T cells accelerate Alzheimer's disease in mice","volume":"18","author":"Machhi","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellimm.2023.104778_b0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","article-title":"Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease","volume":"560","author":"Da Mesquita","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2023.104778_b0115","doi-asserted-by":"crossref","unstructured":"N.C. C, M.A. Lynch, The role of the immune system in driving neuroinflammation, Brain and neuroscience advances, 4 (2020) 2398212819901082.","DOI":"10.1177\/2398212819901082"},{"key":"10.1016\/j.cellimm.2023.104778_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.03100","article-title":"Treg Heterogeneity, Function, and Homeostasis","volume":"10","author":"Shevyrev","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0125","article-title":"The complex role of regulatory T cells in immunity and aging","volume":"11","author":"Rocamora-Reverte","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080939","article-title":"Transcriptional regulation of differentiation and functions of effector T regulatory cells","volume":"8","author":"Koizumi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cellimm.2023.104778_b0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/febs.15743","article-title":"FOXP3(+) regulatory T cells and age-related diseases","volume":"289","author":"Deng","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.cellimm.2023.104778_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1154575","article-title":"Regulatory T cells in peripheral tissue tolerance and diseases","volume":"14","author":"Cheru","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0145","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.3233\/JPD-223278","article-title":"Therapeutic strategies for immune transformation in parkinson's disease","volume":"12","author":"Saleh","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.cellimm.2023.104778_b0150","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-022-02605-9","article-title":"The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases","volume":"19","author":"DeMaio","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellimm.2023.104778_b0155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"2010","key":"10.1016\/j.cellimm.2023.104778_b0160","first-page":"2261","article-title":"Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease, Journal of immunology (Baltimore","volume":"184","author":"Reynolds","year":"1950","journal-title":"MD"},{"key":"10.1016\/j.cellimm.2023.104778_b0165","first-page":"230","article-title":"The toll-like receptor 2 (TLR2)-related immunopathological responses in the multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"18","author":"Jafarzadeh","year":"2019","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12031-016-0789-5","article-title":"Altered expression of specific transcription factors of Th17 (ROR\u03b3t, ROR\u03b1) and Treg lymphocytes (FOXP3) by peripheral blood mononuclear cells from patients with multiple sclerosis","volume":"60","author":"Etesam","year":"2016","journal-title":"J. Mol. Neurosci.: MN"},{"key":"10.1016\/j.cellimm.2023.104778_b0175","doi-asserted-by":"crossref","first-page":"2153534","DOI":"10.1080\/21645515.2022.2153534","article-title":"Regulatory T cell therapy for multiple sclerosis: breaching (blood-brain) barriers","volume":"18","author":"Verreycken","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.cellimm.2023.104778_b0180","doi-asserted-by":"crossref","unstructured":"J. Reddy, Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R.A. Sobel, K.W. Wucherpfennig, V.K. Kuchroo, Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis, Proceedings of the National Academy of Sciences of the United States of America, 101 (2004) 15434-15439.","DOI":"10.1073\/pnas.0404444101"},{"key":"10.1016\/j.cellimm.2023.104778_b0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbi.2008.09.004","article-title":"Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy","volume":"23","author":"Sloane","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.cellimm.2023.104778_b0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/21678421.2020.1752246","article-title":"The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential","volume":"21","author":"Giovannelli","year":"2020","journal-title":"Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration"},{"key":"10.1016\/j.cellimm.2023.104778_b0195","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/WCO.0000000000000983","article-title":"Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration","volume":"34","author":"Appel","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.cellimm.2023.104778_b0200","doi-asserted-by":"crossref","first-page":"e89530","DOI":"10.1172\/jci.insight.89530","article-title":"ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity","volume":"2","author":"Beers","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.cellimm.2023.104778_b0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.imlet.2022.06.005","article-title":"Brain-resident regulatory T cells and their role in health and disease","volume":"248","author":"Liston","year":"2022","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cellimm.2023.104778_b0210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.1927","article-title":"Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke","volume":"15","author":"Liesz","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2023.104778_b0215","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.tins.2021.07.005","article-title":"T cells direct microglial repair of white matter after stroke","volume":"44","author":"Zera","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.cellimm.2023.104778_b0220","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1038\/s41598-019-45433-3","article-title":"The Characterization of Regulatory T-Cell Profiles in Alzheimer's Disease and Multiple Sclerosis","volume":"9","author":"Ciccocioppo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2023.104778_b0225","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3389\/fimmu.2018.01213","article-title":"Imbalance of Circulating T(h)17 and Regulatory T Cells in Alzheimer's Disease: A Case Control Study","volume":"9","author":"Oberstein","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0230","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/ene.14360","article-title":"Exploratory study on immune phenotypes in Alzheimer's disease and vascular dementia","volume":"27","author":"D'Angelo","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.cellimm.2023.104778_b0235","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3233\/JAD-2010-091696","article-title":"PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer's disease","volume":"21","author":"Saresella","year":"2010","journal-title":"Journal of Alzheimer's Disease : JAD"},{"key":"10.1016\/j.cellimm.2023.104778_b0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12974-019-1554-9","article-title":"Beneficial effects of curtailing immune susceptibility in an Alzheimer's disease model","volume":"16","author":"Di Benedetto","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellimm.2023.104778_b0245","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5114\/ceji.2015.56961","article-title":"Matrine improves cognitive impairment and modulates the balance of Th17\/Treg cytokines in a rat model of A\u03b21-42-induced Alzheimer's disease","volume":"40","author":"Zhang","year":"2015","journal-title":"Central-Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12974-016-0476-z","article-title":"Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer's disease","volume":"13","author":"Ye","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellimm.2023.104778_b0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2009-1015","article-title":"Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease","volume":"17","author":"Larbi","year":"2009","journal-title":"J. Alzheimer's Dis.: JAD"},{"key":"10.1016\/j.cellimm.2023.104778_b0260","doi-asserted-by":"crossref","first-page":"69347","DOI":"10.18632\/oncotarget.12469","article-title":"Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model","volume":"7","author":"Baek","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2023.104778_b0265","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/brain\/awv408","article-title":"Regulatory T cells delay disease progression in Alzheimer-like pathology","volume":"139","author":"Dansokho","year":"2016","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.cellimm.2023.104778_b0270","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11481-015-9639-4","article-title":"A perspective on roles played by innate and adaptive immunity in the pathobiology of neurodegenerative disorders","volume":"10","author":"Gendelman","year":"2015","journal-title":"J. Neuroimmune Pharmacol.: Off. J. Soc. NeuroImmune Pharmacol."},{"key":"10.1016\/j.cellimm.2023.104778_b0275","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fimmu.2017.00783","article-title":"Differential phenotypes of myeloid-derived suppressor and T regulatory cells and cytokine levels in amnestic mild cognitive impairment subjects compared to mild alzheimer diseased patients","volume":"8","author":"Le Page","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0280","article-title":"Mild cognitive impairment patients have higher regulatory T-cell proportions compared with alzheimer's disease-related dementia patients","volume":"12","author":"Fu","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cellimm.2023.104778_b0285","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2023.104778_b0290","doi-asserted-by":"crossref","first-page":"e69129","DOI":"10.1371\/journal.pone.0069129","article-title":"Systemic transplantation of human umbilical cord derived mesenchymal stem cells-educated T regulatory cells improved the impaired cognition in A\u03b2PPswe\/PS1dE9 transgenic mice","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2023.104778_b0295","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","article-title":"Innate immunity in Alzheimer's disease","volume":"16","author":"Heneka","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0300","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1002\/gps.4660","article-title":"Mutual effect of cerebral amyloid \u03b2 and peripheral lymphocytes in cognitively normal older individuals","volume":"32","author":"Yasuno","year":"2017","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.cellimm.2023.104778_b0305","first-page":"826","article-title":"Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice","volume":"140","author":"Alves","year":"2017","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.cellimm.2023.104778_b0310","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.7150\/thno.75965","article-title":"Adoptive therapy with amyloid-\u03b2 specific regulatory T cells alleviates Alzheimer's disease","volume":"12","author":"Yang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cellimm.2023.104778_b0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/187152710791012071","article-title":"Microglia and inflammation in Alzheimer's disease","volume":"9","author":"Mandrekar-Colucci","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.cellimm.2023.104778_b0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer's disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.cellimm.2023.104778_b0325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","article-title":"Glial activation and inflammation along the Alzheimer's disease continuum","volume":"16","author":"Nordengen","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellimm.2023.104778_b0330","doi-asserted-by":"crossref","unstructured":"M.M. Tiemessen, A.L. Jagger, H.G. Evans, M.J. van Herwijnen, S. John, L.S. Taams, CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages, Proceedings of the National Academy of Sciences of the United States of America, 104 (2007) 19446-19451.","DOI":"10.1073\/pnas.0706832104"},{"key":"10.1016\/j.cellimm.2023.104778_b0335","doi-asserted-by":"crossref","first-page":"fcaa112","DOI":"10.1093\/braincomms\/fcaa112","article-title":"Restoring regulatory T-cell dysfunction in Alzheimer's disease through ex vivo expansion","volume":"2","author":"Faridar","year":"2020","journal-title":"Brain Communications"},{"key":"10.1016\/j.cellimm.2023.104778_b0340","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The Role of Astrocytes in CNS Inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0345","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nm838","article-title":"Adult mouse astrocytes degrade amyloid-beta in vitro and in situ","volume":"9","author":"Wyss-Coray","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2023.104778_b0350","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/glia.20599","article-title":"Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease","volume":"56","author":"Pihlaja","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.cellimm.2023.104778_b0355","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","article-title":"Astrocyte Crosstalk in CNS Inflammation","volume":"108","author":"Linnerbauer","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.cellimm.2023.104778_b0360","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fncel.2015.00278","article-title":"Elusive roles for reactive astrocytes in neurodegenerative diseases","volume":"9","author":"Ben Haim","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.cellimm.2023.104778_b0365","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2023.104778_b0370","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12974-023-02702-3","article-title":"Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology","volume":"20","author":"Stym-Popper","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellimm.2023.104778_b0375","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","article-title":"Neurotoxic reactive astrocytes induce cell death via saturated lipids","volume":"599","author":"Guttenplan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2023.104778_b0380","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6295","article-title":"Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice","volume":"9","author":"Shi","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cellimm.2023.104778_b0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113008","article-title":"Alzheimer's Disease: From Immune Homeostasis to Neuroinflammatory Condition","volume":"23","author":"Princiotta Cariddi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2023.104778_b0390","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbi.2010.12.004","article-title":"Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer\u2019s disease","volume":"25","author":"Saresella","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cellimm.2023.104778_b0395","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4049\/jimmunol.1200947","article-title":"IFN-\u03b3 Production by Amyloid \u03b2\u2013Specific Th1 Cells Promotes Microglial Activation and Increases Plaque Burden in a Mouse Model of Alzheimer\u2019s Disease","volume":"190","author":"Browne","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0400","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nbd.2008.12.015","article-title":"Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS","volume":"34","author":"Cao","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cellimm.2023.104778_b0405","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bbi.2010.01.003","article-title":"Activation of mixed glia by A\u03b2-specific Th1 and Th17 cells and its regulation by Th2 cells","volume":"24","author":"McQuillan","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.cellimm.2023.104778_b0410","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.4049\/jimmunol.1000435","article-title":"Netrin-1 regulates Th1\/Th2\/Th17 cytokine production and inflammation through UNC5B receptor and protects kidney against ischemia\u2013reperfusion injury","volume":"185","author":"Tadagavadi","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0415","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fnagi.2019.00124","article-title":"Decreased Netrin-1 and Correlated Th17\/Tregs Balance Disorder in A\u03b2(1\u201342) Induced Alzheimer's Disease Model Rats","volume":"11","author":"Sun","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cellimm.2023.104778_b0420","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","article-title":"Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease","volume":"577","author":"Gate","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2023.104778_b0425","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpsychires.2006.01.010","article-title":"Altered lymphocyte distribution in Alzheimer's disease","volume":"41","author":"Richartz-Salzburger","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.cellimm.2023.104778_b0430","doi-asserted-by":"crossref","first-page":"1973834","DOI":"10.1155\/2016\/1973834","article-title":"New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis","volume":"2016","author":"Adamczyk","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cellimm.2023.104778_b0435","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/708659","article-title":"Immunology and oxidative stress in multiple sclerosis: clinical and basic approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0440","doi-asserted-by":"crossref","first-page":"3164734","DOI":"10.1155\/2016\/3164734","article-title":"The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults","volume":"2016","author":"Nita","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cellimm.2023.104778_b0445","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arcmed.2020.04.019","article-title":"Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection","volume":"51","author":"Delgado-Roche","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.cellimm.2023.104778_b0450","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/eji.202049112","article-title":"Modulating oxidative stress counteracts specific antigen-induced regulatory T-cell apoptosis in mice","volume":"51","author":"Zhang","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0455","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: Central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cellimm.2023.104778_b0460","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/ijms24033022","article-title":"Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin","volume":"24","author":"Tchekalarova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2023.104778_b0465","doi-asserted-by":"crossref","unstructured":"G. Plascencia-Villa G. Perry Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer's Disease, Antioxidants 12 2023 (Basel, Switzerland).","DOI":"10.3390\/antiox12081628"},{"key":"10.1016\/j.cellimm.2023.104778_b0470","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen peroxide mediates amyloid \u03b2 protein toxicity","volume":"77","author":"Behl","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2023.104778_b0475","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1523\/JNEUROSCI.17-03-01046.1997","article-title":"Amyloid \u03b2-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation","volume":"17","author":"Mark","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cellimm.2023.104778_b0480","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cellimm.2014.02.003","article-title":"Increased oxidative stress and the apoptosis of regulatory T cells in obese mice but not resistant mice in response to a high-fat diet","volume":"288","author":"Wang","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0485","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/apm.12735","article-title":"Regulatory T cell subsets in peripheral blood of celiac disease patients and TLR2 expression: correlation with oxidative stress","volume":"125","author":"Kumar","year":"2017","journal-title":"APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica"},{"key":"10.1016\/j.cellimm.2023.104778_b0490","doi-asserted-by":"crossref","first-page":"2526174","DOI":"10.1155\/2016\/2526174","article-title":"Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus Erythematosus","volume":"2016","author":"Yang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cellimm.2023.104778_b0495","first-page":"2716","article-title":"Metabolic Control of Treg Cell Stability","volume":"10","author":"Shi","year":"2019","journal-title":"Plasticity, and Tissue-Specific Heterogeneity, Frontiers in Immunology"},{"key":"10.1016\/j.cellimm.2023.104778_b0500","doi-asserted-by":"crossref","DOI":"10.3390\/nu15010061","article-title":"Low Serum Vitamin D Status Is Associated with Incident Alzheimer's Dementia in the Oldest Old","volume":"15","author":"Melo van Lent","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.cellimm.2023.104778_b0505","doi-asserted-by":"crossref","DOI":"10.3390\/nu9070670","article-title":"Vitamin C, Aging and Alzheimer's Disease","volume":"9","author":"Monacelli","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.cellimm.2023.104778_b0510","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1447-0594.2011.00786.x","article-title":"Vitamin A and Alzheimer's disease","volume":"12","author":"Ono","year":"2012","journal-title":"Geriatr. Gerontol. Int."},{"issue":"2011","key":"10.1016\/j.cellimm.2023.104778_b0515","first-page":"3299","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets, Journal of immunology (Baltimore","volume":"186","author":"Michalek","year":"1950","journal-title":"MD"},{"key":"10.1016\/j.cellimm.2023.104778_b0520","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1515\/jbcpp-2013-0001","article-title":"Dichloroacetate at therapeutic concentration alters glucose metabolism and induces regulatory T-cell differentiation in alloreactive human lymphocytes","volume":"24","author":"Eleftheriadis","year":"2013","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.cellimm.2023.104778_b0525","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.3389\/fimmu.2019.02839","article-title":"Metabolic Pathways Involved in Regulatory T Cell Functionality","volume":"10","author":"Kempkes","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0530","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2023.104778_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02005","article-title":"Metabolic Optimisation of Regulatory T Cells in Transplantation","volume":"11","author":"Atif","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0540","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","article-title":"Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain, Biochimica et Biophysica Acta (BBA) -","author":"Butterfield","year":"2014","journal-title":"Molecular Basis of Disease"},{"key":"10.1016\/j.cellimm.2023.104778_b0545","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2007.05.011","article-title":"Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration","volume":"188","author":"Rosenkranz","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0550","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1523\/JNEUROSCI.0600-04.2004","article-title":"Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration, The Journal of neuroscience : the official journal of the Society for","volume":"24","author":"Kipnis","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.cellimm.2023.104778_b0555","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.18632\/oncotarget.4930","article-title":"Splenocytes derived from young WT mice prevent AD progression in APPswe\/PSENldE9 transgenic mice","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2023.104778_b0560","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology","volume":"85","author":"Guillot-Sestier","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.cellimm.2023.104778_b0565","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.isci.2019.05.039","article-title":"CD4 T cells induce A subset of MHCII-expressing microglia that attenuates alzheimer pathology","volume":"16","author":"Mittal","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.cellimm.2023.104778_b0570","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.1301707","article-title":"Th1 polarization of T cells injected into the cerebrospinal fluid induces brain immunosurveillance","volume":"192","author":"Fisher","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0575","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1002\/eji.200424883","article-title":"Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells","volume":"34","author":"Avidan","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0580","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s40478-022-01447-z","article-title":"Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease","volume":"10","author":"Faridar","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cellimm.2023.104778_b0585","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1212\/NXI.0000000000000465","article-title":"Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study","volume":"5","author":"Thonhoff","year":"2018","journal-title":"Neurology(r) Neuroimmunology & Neuroinflammation"},{"key":"10.1016\/j.cellimm.2023.104778_b0590","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mehy.2019.01.007","article-title":"Can immunization with bacillus calmette-gu\u00e9rin (BCG) protect against Alzheimer's disease?","volume":"123","author":"Gofrit","year":"2019","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.cellimm.2023.104778_b0595","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbd.2017.02.001","article-title":"Immunization with Bacillus Calmette-Gu\u00e9rin (BCG) alleviates neuroinflammation and cognitive deficits in APP\/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain","volume":"101","author":"Zuo","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cellimm.2023.104778_b0600","doi-asserted-by":"crossref","first-page":"17369","DOI":"10.1038\/s41598-018-35030-1","article-title":"Bee venom phospholipase A2 ameliorates Alzheimer's disease pathology in A\u03b2 vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model","volume":"8","author":"Baek","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2023.104778_b0605","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fnagi.2019.00287","article-title":"Bee venom soluble phospholipase A2 exerts neuroprotective effects in a lipopolysaccharide-induced mouse model of alzheimer's disease via inhibition of nuclear factor-kappa B","volume":"11","author":"Ham","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cellimm.2023.104778_b0610","doi-asserted-by":"crossref","first-page":"24939","DOI":"10.1038\/srep24939","article-title":"Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease","volume":"6","author":"Aytan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2023.104778_b0615","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2018.03.009","article-title":"Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice","volume":"319","author":"Kiyota","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0620","doi-asserted-by":"crossref","unstructured":"M. Jung, S. Lee, S. Park, J. Hong, C. Kim, I. Cho, H.S. Sohn, K. Kim, I.W. Park, S. Yoon, S. Kwon, J. Shin, D. Lee, M. Kang, S. Go, S. Moon, Y. Chung, Y. Kim, B.S. Kim, A Therapeutic Nanovaccine that Generates Anti-Amyloid Antibodies and Amyloid-specific Regulatory T Cells for Alzheimer's Disease, Advanced materials (Deerfield Beach, Fla.), 35 (2023) e2207719.","DOI":"10.1002\/adma.202207719"},{"key":"10.1016\/j.cellimm.2023.104778_b0625","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneuroim.2014.12.007","article-title":"Co-stimulation with TNF receptor superfamily 4\/25 antibodies enhances in-vivo expansion of CD4+CD25+Foxp3+ T cells (Tregs) in a mouse study for active DNA A\u03b242 immunotherapy","volume":"278","author":"Lambracht-Washington","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2023.104778_b0630","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4161\/hv.24830","article-title":"Immunotherapeutic efficiency of a tetravalent A\u03b21-15 vaccine in APP\/PS1 transgenic mice as mouse model for Alzheimer's disease","volume":"9","author":"Guan","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.cellimm.2023.104778_b0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106595","article-title":"Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of Alzheimer's disease","volume":"187","author":"Vellecco","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellimm.2023.104778_b0640","doi-asserted-by":"crossref","first-page":"14204","DOI":"10.1021\/acs.jafc.1c06304","article-title":"Ganoderic Acid A To Alleviate Neuroinflammation of Alzheimer's Disease in Mice by Regulating the Imbalance of the Th17\/Tregs Axis","volume":"69","author":"Zhang","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.cellimm.2023.104778_b0645","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbr.2016.08.025","article-title":"Immunotherapeutic effects of lymphocytes co-cultured with human cord blood-derived multipotent stem cells transplantation on APP\/PS1 mice","volume":"315","author":"He","year":"2016","journal-title":"Behav. Brain Res."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492300117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492300117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:15:00Z","timestamp":1757805300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887492300117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":129,"alternative-id":["S000887492300117X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104778","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential roles of regulatory T cells in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104778"}}